ClinConnect ClinConnect Logo
Search / Trial NCT04850001

Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

Launched by ANHUI MEDICAL UNIVERSITY · Apr 14, 2021

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Magnetic Resonance Imaging Asymptomatic Intracranial Stenosis Patients Cognitive Function Medical Treatment

ClinConnect Summary

This clinical trial, titled "Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study," is looking at how standard medical treatment affects thinking and memory in patients who have narrowing of certain blood vessels in the brain, known as asymptomatic intracranial stenosis. Researchers want to learn if these patients experience cognitive decline over a year and understand the brain changes through specialized imaging techniques. The study is currently recruiting participants, and anyone aged 65 to 74 or 29 to 219 years old can apply, as long as they have at least a 50% narrowing in the internal carotid artery or middle cerebral artery, confirmed by specific imaging tests.

To be eligible, participants must not have had a stroke, seizures, or any serious mental health issues. They also should not have any implanted devices like pacemakers or a history of substance abuse in the past six months. If you join the study, you can expect regular check-ups and brain scans to assess your cognitive health and monitor any changes over time. This trial aims to improve our understanding of how brain health can be maintained in patients with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with intracranial stenosis which was defined as stenosis of 50% or more in Intracranial segment of internal carotid artery and middle cerebral artery (MCA).
  • The degree of stenosis was measured by transcranial doppler, computed magnetic resonance angiography (MRA),tomography angiography (CTA) and digital subtraction angiography (DSA).
  • Exclusion Criteria:
  • History of stroke,transient ischemic attack,seizures or unexplained loss of consciousness.
  • Organic brain defects on T1 or T2 images.
  • Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder).
  • Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator. History of substance abuse within the last 6 months.

About Anhui Medical University

Anhui Medical University, a leading institution in medical education and research in China, is dedicated to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a robust infrastructure and a commitment to ethical research practices, the university fosters collaboration among multidisciplinary teams to explore novel therapeutic interventions and improve patient outcomes. Its focus on translational medicine and public health reflects a deep commitment to addressing pressing health challenges both locally and globally. Through its clinical trial initiatives, Anhui Medical University aims to contribute significantly to the evidence base in medicine and enhance the quality of care provided to diverse populations.

Locations

Hefei, Anhui, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials